Delivery Order SPE2DB22D3016-SPE2DB24FAEU6
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,562,139,657 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $1,199.86 and a completion date of September 13, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB24FT93T, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,693.49 delivery order contract is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used for the emergency treatment of opioid overdose. The contract has a firm fixed price pricing type and an ultimate completion date of May 1, 2024. This award is part of a larger Indefinite Delivery...
- This federal contract award, valued at $3,010.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,043,264 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a value of $4,152.76 and is for the delivery of 4,557,205,143 units of Naloxone HCL 4 mg nasal spray. The contract was awarded on May 12, 2022, with a completion date of May 13, 2022. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up...
- This federal contract award, valued at $4,707.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,941,949 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to reverse opioid overdoses. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $10,007.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the supply of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdose. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,558,986,354 units of Naloxone HCL 4 mg nasal spray. The contract has a ceiling value of $11,337.85 and an ultimate completion date of November 4, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $14,421.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Naloxone Hydrochloride 4 mg Nasal Spray, a critical medication used to reverse opioid overdoses. This is a delivery order contract with a firm fixed price type and an ultimate completion date of May 15, 2023. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The $2,772.75 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,560 units of 4 mg Naloxone HCl nasal spray over a one-year period. The $1,859.02 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA) on February 22, 2023, with a completion date of February 23, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAEU6Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) with a Firm Fixed Price (FFP) type, valued at $17,468.20. The award is from the Defense Logistics Agency (DLA) for the supply of 4 mg Naloxone Hydrochloride Nasal Spray, a critical medication used to treat opioid overdose. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2022. This DO is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 12/4/23 |